Resultados da pesquisa - ((((drug dev) OR (((drug deal) OR (drugs deal))))) OR (drug de)) devel ther*

1

MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866

Por Huang, Peixin, Lee, Mark W, Sadrerafi, Keivan, Heruth, Daniel P, Zhang, Li Q, Maulik, Dev, Ye, Shui Qing
Publicado no Drug Des Devel Ther (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

A carregar...

Women taking the “blue pill” (sildenafil citrate): such a big deal?

Por Lo Monte, Giuseppe, Graziano, Angela, Piva, Isabella, Marci, Roberto
Publicado no Drug Des Devel Ther (2014)

“... are still conflicting and the drug is not devoid of adverse effects. Furthermore, female sexual arousal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

A carregar...

Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii

Por de Leeuw, Erik PH
Publicado em 2014

“... compound that targets Lipid II is described that acts against multi-drug resistant isolates of A. baumannii...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

A carregar...

The role of taxanes in triple-negative breast cancer: literature review

Por Mustacchi, Giorgio, De Laurentiis, Michelino
Publicado no Drug Des Devel Ther (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

A carregar...

Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays

Por Rezende, Vinicius Marcondes, Rivellis, Ariane, Novaes, Mafalda Megumi Yoshinaga, de Alencar Fisher Chamone, Dalton, Bendit, Israel
Publicado em 2013

“... applied in routine therapeutic drug monitoring in the hospital service....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

A carregar...

Hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors

Por de Oliveira Magalhães, Uiaran, de Souza, Alessandra Mendonça Teles, Albuquerque, Magaly Girão, de Brito, Monique Araújo, Bello, Murilo Lamim, Cabral, Lucio Mendes, Rodrigues, Carlos Rangel
Publicado em 2013

“... immunodeficiency virus (HIV). Treatment with antiretroviral drugs is the best option for viral suppression...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

A carregar...

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date

Por Squitieri, Ferdinando, de Yebenes, Justo Garcia
Publicado no Drug Des Devel Ther (2015)

“... it might be a neuroprotective and disease-modifying drug. Data from ongoing clinical trials of pridopidine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

A carregar...

Antibiotic-modifying activity of riachin, a non-cyanogenic cyanoglycoside extracted from Bauhinia pentandra

Por de Farias, Pablo Antonio Maia, Figueredo, Fernando Gomes, Lucas, Aline Maria Brito, de Moura, Rafael Barbosa, Coutinho, Henrique Douglas Melo, da Silva, Tania Maria Sarmento, Martin, Ana Luiza de Aguiar Rocha, Fonteles, Marta Maria de França
Publicado no Drug Des Devel Ther (2015)

“... years, especially for new drugs with antibiotic potential. Accordingly, the aim of this study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

A carregar...

Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic...

Por Scheinberg, Morton, Pott Júnior, Henrique, Macêdo, Eduardo de Almeida, Bocchi de Oliveira, Monalisa Fernanda, Ecclissato, Christina, Amazonas, Roberto Bleuel
Publicado no Drug Des Devel Ther (2018)

“... 14 days of therapy, the difference was 0.45 mm (95% CI, −3.29 to 4.19 mm). The most common adverse...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

A carregar...

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis

Por Mazo, Daniel FC, de Oliveira, Marcelo G, Pereira, Isabel VA, Cogliati, Bruno, Stefano, José T, de Souza, Gabriela FP, Rabelo, Fabíola, Lima, Fabiana R, Alves, Venâncio A Ferreira, Carrilho, Flair J, de Oliveira, Claudia PMS
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

A carregar...

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma

Por Zhong, Jian-Hong, Xiang, Bang-De, Li, Le-Qun
Publicado no Drug Des Devel Ther (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

A carregar...

Aminaphtone in the control of gingival bleeding in children

Por Pereira de Godoy, José Maria, Macedo Paizan, Mara Lucia
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

A carregar...

Changing the face of hepatitis C management – the design and development of sofosbuvir

Por Noell, Bennett C, Besur, Siddesh V, deLemos, Andrew S
Publicado no Drug Des Devel Ther (2015)

“...The availability of direct-acting antiviral (DAA) therapy has launched a new era in the management...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

A carregar...

A novel small-molecule inhibitor of HIV-1 entry

Por Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Publicado no Drug Des Devel Ther (2015)

“...BACKGROUND: Antiretroviral therapy has transformed HIV-1 infection into a managed condition...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

A carregar...

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection

Por Mascellino, Maria Teresa, Porowska, Barbara, De Angelis, Massimiliano, Oliva, Alessandra
Publicado no Drug Des Devel Ther (2017)

“... regarding eradication success rates of culture-guided and empiric therapies. The empiric therapy and the one...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

A carregar...

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado no Drug Des Devel Ther (2016)

“... biological processes made this signaling pathway an attractive therapeutic target in oncology, particularly...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

A carregar...

Analysis of HSP90-related folds with MED-SuMo classification approach

Por Doppelt-Azeroual, Olivia, Moriaud, Fabrice, Delfaud, François, de Brevern, Alexandre G
Publicado em 2009

“... with functional predictions and are extremely valuable steps in a drug design process. In this research area, MED...”
Obter o texto integral
Obter o texto integral

Artigo

18

A carregar...

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

Por De Luca, Rossella, Blasi, Livio, Alù, Massimiliano, Gristina, Valerio, Cicero, Giuseppe
Publicado no Drug Des Devel Ther (2018)

“... well-tolerated and effective treatment for patients affected by MPC. The drug showed an improved...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

A carregar...

Defective DNA repair mechanisms in prostate cancer: impact of olaparib

Por De Felice, Francesca, Tombolini, Vincenzo, Marampon, Francesco, Musella, Angela, Marchetti, Claudia
Publicado no Drug Des Devel Ther (2017)

“...) proteins play a key role in DNA repair mechanisms and represent a valid target for new therapies. Olaparib...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

A carregar...

The effectiveness of long-term course of Sterimar Mn nasal spray for treatment of the recurrence rates of acute allergic rhinitis in patients with chronic allergic rhinitis

Por Grasso, Michele, de Vincentiis, Marco, Agolli, Griselda, Cilurzo, Francesco, Grasso, Raffaele
Publicado no Drug Des Devel Ther (2018)

“... with chronic AR is very high in terms of therapy and quality of life. AR represents a worldwide health problem...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

Refinar a Pesquisa